comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-02 11:47:39 - browse：9297

Axovant Sciences(AXON) is the main event in biotech’s September cavalcade of clinical trial readouts, but while we wait, it’s a good idea to prep for important — and stock-moving — data releases from Zogenix(ZGNX) and Amicus Therapeutics(FOLD).

Zogenix’s lead drug, called ZX008, is a low-dose liquid formulation of the old serotonin booster fenfluramine. The company is developing ZX008 to treat children with Dravet syndrome, a rare and severe type of epilepsy.

You might remember fenfluramine as part of the “fen-phen” obesity regimen that was pulled from the market in 1997 because fenfluramine (at a higher dose) caused severe damage to people’s heart valves.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： What we need to know about Arena Bioworks

WSS

What causes rare myocarditis in young men after Covid vaccines?

FDA drug safety: Singulair case shows systemic surveillance flaws

New Alzheimer's drugs heat up race for early detection blood tests

The haunting brain science of long Covid

Vertigo drug brings hope for rare neuron disorder, Niemann

CDC Director Mandy Cohen on transparency, trust, and health

entertainment

comprehensive

Wikipedia

How one medical school became remarkably diverse

Juul spent big to court Black leaders to promote its e

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Vertex non

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Biogen says it will cut costs by $700 million, slash 1,000 jobs

As demand for Covid shots wanes, Moderna seeks its next success

New Ultima Genomics DNA sequencer can read genome for $100

United colonoscopy coverage change 'may cost lives,' doctors say

FDA drug safety: Singulair case shows systemic surveillance flaws

Wikipedia

Biden administration opens offers in Medicare drug price negotiations

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Commercial surrogacy can be ethical, despite pope’s claims

Cognito secures funding to test medical device for Alzheimer's

Why patients can’t get everything they want on drug pricing

Juul spent big to court Black leaders to promote its e

explore

explore

explore

hotspot